J.D. Bradley

642 total citations
28 papers, 324 citations indexed

About

J.D. Bradley is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J.D. Bradley has authored 28 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 15 papers in Radiation and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J.D. Bradley's work include Advanced Radiotherapy Techniques (15 papers), Lung Cancer Diagnosis and Treatment (13 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). J.D. Bradley is often cited by papers focused on Advanced Radiotherapy Techniques (15 papers), Lung Cancer Diagnosis and Treatment (13 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). J.D. Bradley collaborates with scholars based in United States, Canada and Netherlands. J.D. Bradley's co-authors include Clifford G. Robinson, Michael Roach, Imran Zoberi, Rojano Kashani, Sasa Mutic, Issam El Naqa, Joseph O. Deasy, J. Contreras, Jan P. van Meerbeeck and Parag J. Parikh and has published in prestigious journals such as Blood, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

J.D. Bradley

26 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.D. Bradley United States	8	215	178	159	59	42	28	324
Katherina P. Farr Denmark	10	207 1.0×	192 1.1×	194 1.2×	64 1.1×	23 0.5×	15	365
Morten Nielsen Denmark	10	184 0.9×	217 1.2×	200 1.3×	34 0.6×	25 0.6×	30	315
Takashi Shintani Japan	13	241 1.1×	105 0.6×	186 1.2×	103 1.7×	38 0.9×	32	363
Jia-Yang Lu China	10	196 0.9×	141 0.8×	111 0.7×	30 0.5×	54 1.3×	32	333
Garrick C. Chang United States	4	242 1.1×	145 0.8×	106 0.7×	110 1.9×	23 0.5×	5	346
Lawrence B. Marks United States	6	239 1.1×	191 1.1×	249 1.6×	38 0.6×	44 1.0×	7	378
T Ganesh India	10	134 0.6×	249 1.4×	222 1.4×	23 0.4×	43 1.0×	61	359
M. Khodri France	9	177 0.8×	176 1.0×	95 0.6×	45 0.8×	67 1.6×	20	326
Zhiyong Xu China	9	122 0.6×	139 0.8×	151 0.9×	20 0.3×	36 0.9×	36	296
G. Siepe Italy	9	215 1.0×	89 0.5×	102 0.6×	82 1.4×	34 0.8×	32	310

Countries citing papers authored by J.D. Bradley

Since Specialization

Citations

This map shows the geographic impact of J.D. Bradley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.D. Bradley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.D. Bradley more than expected).

Fields of papers citing papers by J.D. Bradley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.D. Bradley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.D. Bradley. The network helps show where J.D. Bradley may publish in the future.

Co-authorship network of co-authors of J.D. Bradley

This figure shows the co-authorship network connecting the top 25 collaborators of J.D. Bradley. A scholar is included among the top collaborators of J.D. Bradley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.D. Bradley. J.D. Bradley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simone, Charles B., J.H. Heinzerling, Kathryn F. Mileham, et al.. (2024). NRG LU008: Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy (SBRT) Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC). International Journal of Radiation Oncology*Biology*Physics. 120(2). e63–e63.

Chun, Stephen G., Chen Hu, H. Choy, et al.. (2023). OA17.04 Long-Term Outcomes by Radiation Technique for Locally-Advanced Non-small Lung Cancer: A Secondary Analysis of NRG Oncology-RTOG 0617 at 5-years. Journal of Thoracic Oncology. 18(11). S83–S84. 1 indexed citations

Castillo, Richard, Manali Rupji, Rafael López Castro, et al.. (2021). Sparing Functional Lung Using Optimized Volumetric Modulated Arc Therapy in Thoracic Radiation for Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 111(3). e456–e457. 1 indexed citations

Higgins, Kristin, Walter J. Curran, Stephen V. Liu, et al.. (2020). Patterns of Disease Progression after Carboplatin/Etoposide + Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC). International Journal of Radiation Oncology*Biology*Physics. 108(5). 1398–1398. 18 indexed citations

Gabani, Prashant, Hetal Patel, S Goddu, et al.. (2019). Clinical outcomes and toxicity of proton beam radiation therapy for re-irradiation of locally recurrent breast cancer. Clinical and Translational Radiation Oncology. 19. 116–122. 27 indexed citations

DeWees, T.A., et al.. (2018). Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung Cancers. Clinical Lung Cancer. 20(2). 107–116. 20 indexed citations

Henke, Lauren E., J. Contreras, Bin Cai, et al.. (2018). Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-Year Clinical Experience. Clinical Oncology. 30(11). 720–727. 99 indexed citations

Geng, H., Haoyu Zhong, T Giaddui, et al.. (2017). Knowledge Engineering–Based Quality Evaluation of RTOG 1308 Proton Treatment plans. International Journal of Radiation Oncology*Biology*Physics. 99(2). E661–E662. 1 indexed citations

Contreras, J., Anupama Chundury, Francisco J. Reynoso, et al.. (2017). Proton Therapy Reirradiation for Thoracic Recurrences: Toxicity and Outcomes. International Journal of Radiation Oncology*Biology*Physics. 99(2). E448–E448. 1 indexed citations

10.

Bradley, J.D., Shirley D’Sa, Charalampia Kyriakou, et al.. (2016). Vial Sharing of Bortezomib Is Logistically Feasible and Significantly Reduces Drug Wastage and the Cost of Myeloma Treatment. Blood. 128(22). 5956–5956. 7 indexed citations

11.

Bezjak, Andrea, Rebecca Paulus, Laurie Gaspar, et al.. (2016). OC-0136: Primary Study Endpoint Analysis of NRG Oncology/RTOG 0813 Trial of SBRT for centrally located NSCLC. Radiotherapy and Oncology. 119. S61–S62. 5 indexed citations

12.

Giaddui, T, Charles B. Simone, Radhe Mohan, et al.. (2015). Evaluation of Lung IMRT Plans Quality Using a Knowledge-Based Engineering Tool. International Journal of Radiation Oncology*Biology*Physics. 93(3). S30–S31. 1 indexed citations

13.

Chun, Stephen G., Chen Hu, H. Choy, et al.. (2015). Comparison of 3-D Conformal and Intensity Modulated Radiation Therapy Outcomes for Locally Advanced Non-Small Cell Lung Cancer in NRG Oncology/RTOG 0617. International Journal of Radiation Oncology*Biology*Physics. 93(3). S1–S2. 24 indexed citations

14.

Rankine, Leith, Bin Cai, Rojano Kashani, et al.. (2015). Implementation of Real-Time, Real-Anatomy Tracking and Radiation Beam Control on the First MR-IGRT Clinical System. International Journal of Radiation Oncology*Biology*Physics. 93(3). S115–S115. 2 indexed citations

15.

Gore, Elizabeth, Chen Hu, A. Sun, et al.. (2015). NRG Oncology/RTOG 0937: Randomized Phase 2 Study Comparing Prophylactic Cranial Irradiation (PCI) Alone to PCI and Consolidative Extracranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC). International Journal of Radiation Oncology*Biology*Physics. 94(1). 5–5. 10 indexed citations

16.

Speirs, Christina K., Sana Rehman, Maria A. Velez, et al.. (2014). Comprehensive Analysis of Dosimetric Predictors of Overall Survival for Stage III Non-Small Cell Lung Cancer (NSCLC) Treated With Definitive Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 90(1). S667–S667. 2 indexed citations

17.

Machtay, Mitchell, Fenghai Duan, Bradley J. Snyder, et al.. (2011). Can Tumor FDG-PET Scan Uptake (SUV) Predict Local Control in Stage III NSCLC? Preliminary Results from ACRIN 6668/RTOG 0235. International Journal of Radiation Oncology*Biology*Physics. 81(2). S134–S135. 1 indexed citations

18.

Oberije, Cary, Dirk De Ruysscher, Steven Petit, et al.. (2010). Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients. Radiotherapy and Oncology. 97(3). 455–461. 63 indexed citations

19.

Rosenzweig, Kenneth E., Benjamin Movsas, J.D. Bradley, et al.. (2009). ACR Appropriateness Criteria® on Nonsurgical Treatment for Non–Small-Cell Lung Cancer: Poor Performance Status or Palliative Intent. Journal of the American College of Radiology. 6(2). 85–95. 7 indexed citations

20.

Akdim, Fatima, Mieke D. Trip, Eric J.G. Sijbrands, et al.. (2007). PO23-746 ISIS 301012, AN ANTISENSE INHIBITOR OF APO B, PRODUCES SIGNIFICANT ADDITIONAL REDUCTION OF LDL-C & APOB IN HYPERCHOLESTEROLEMIC SUBJECTS ON STATINS NOT MEETING TARGET. Atherosclerosis Supplements. 8(1). 198–199. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact